Harsukh Savalia
Geriatric Psychiatry · Cerritos, CANPI 1821204900
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,691 and has fallen 67.7% since, to $868 in 2025. Among geriatric psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 189 payments — averaging $48.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sunovion Pharmaceuticals Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Vanda Pharmaceuticals Inc.$730
- Teva Pharmaceuticals USA, Inc.$728
- plus $2K from 9 others
What the payments were for
- Food & beverage$9,11599%
- Education$771%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $1,876 |
| Sunovion Pharmaceuticals Inc. | 32 | $1,520 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $1,186 |
| Otsuka America Pharmaceutical, Inc. | 28 | $1,135 |
| Vanda Pharmaceuticals Inc. | 18 | $730 |
| Teva Pharmaceuticals USA, Inc. | 11 | $728 |
| Johnson & Johnson | 4 | $572 |
| Alkermes, Inc. | 6 | $486 |
| Axsome Therapeutics, Inc. | 4 | $377 |
| Idorsia Pharmaceuticals US Inc | 2 | $236 |
| E.r. Squibb & Sons, L.L.C. | 1 | $133 |
| Neurocrine Biosciences, Inc. | 1 | $118 |
| Eisai Inc. | 2 | $49 |
| Tris Pharma Inc | 1 | $30 |
| Cranial Technologies, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$1,097
- ARISTADA$903
- CAPLYTA$838
- LATUDA$819
- REXULTI$591
- INVEGA SUSTENNA$572
- LYBALVI$516
- Fanapt$500
- INVEGA TRINZA$422
- Austedo XR$360
- ABILIFY MAINTENA$248
- Auvelity$246
- QUVIVIQ$236
- ARISTADA INITIO$226
- COBENFY$133
- ABILIFY ASIMTUFII$125
- UZEDY$119
- INGREZZA$118
- AUSTEDO$117
How this compares
$9,192 in reported general payments places this provider in the 90th percentile of 46 geriatric psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium | 25 | $950 |
| Clozapine | 12 | $633 |
| Risperidone | 44 | $437 |
| Quetiapine Fumarate | 18 | $126 |
| Aripiprazole | 12 | $85 |
| Fluoxetine Hcl | 12 | $43 |
| Trazodone Hcl | 15 | $33 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in Cerritos
- David SultzerLos Angeles$203K
- Kristine YaffeSan Francisco$40K
- James NelsonSan Francisco$31K
- Samir SabbagMonterey$15K
- Barbara HuynhLos Angeles$4K
- Phillip GrobSanta Rosa$3K
- Jasdeep AulakhPatton$3K
- Kyle BechazLos Angeles$1K
- Beverly ChangRoseville$842
- Izzet YazganCapitola$785
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.